Carisoprodol 350 mg

1 INDICATIONS AND USAGE Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. Limitation of Use Carisoprodol should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration. [ see Dosage and Administration (2) ]. Carisoprodol is a muscle relaxant indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults. (1) Limitations of Use Should only be used for acute treatment periods up to two or three weeks ( 1 )

oxford pharmaceuticals, llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] rash` `[5] rheumatoid arthritis` `[6] abdominal discomfort` `[7] off label use` `[8] alopecia` `[9] systemic lupus erythematosus` `[10] glossodynia`

2 years ago

ROUND WHITE O 111

2 years ago

O 111 ROUND WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 350 mg Tablets: round, convex, white tablets, inscribed with 111 on one side and “O” on the other side; available in bottles of 100 (NDC 69584-111-10), bottles of 500 (NDC 69584-111-50) and bottles of 1000 (NDC 69584-111-90). Storage Store at controlled room temperature 20° - 25°C (68° - 77°F).

More pills like ROUND O 111

Related Pills

Carisoprodol 350 MG Oral Tablet

oxford pharmaceuticals, llc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site